Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC transplantation therapy
Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs
Porton Advanced’s End-to-End CDMO Solutions Accelerates IND Approval of Tasly’s Innovative Dual-Targeting CAR-T Therapy
Porton Advanced Supports Immunofoco’s Second IND Clearance from China’s CDE for EpCAM CAR-T Therapy in Solid Tumors
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development
Porton Advanced Congratulates Esteemed Partner Lion TCR on IND Approval from NMPA for mRNA TCR-T Cell Therapy GZL-016 in Hepatitis B-Related Liver Cancer
